Phase 1/2a Clinical Trial of Gene-corrected Autologous Cell Therapy for Recessive Dystrophic Epidermolysis Bullosa
 Shaundra Eichstadt, MD
Tufts Medical Center
Mentor: Joseph Fowler, MD
University of Louisville
|
|
|
|
|
|
Revisiting the Association Between Skin Toxicity and Better Response in Melanoma Patients Treated with Immune Checkpoint Inhibitors
 Nicholas Gulati, MD, PhD
NYU Grossman School of Medicine
 Mentor: Vincent DeLeo, MD
USC – Keck School of Medicine
|
|
Topical Cantharidin Revisited: A Phase 2 Study on a Commercially-Viable Formulation of Cantharidin (VP-102) for the Treatment of Molluscum Contagiosum
 Anthony Guzman, MD
Albert Einstein College of Medicine
 Mentor: Ellen Frankel, MD
Kent Hospital – Warwick, RI
|
|
|
|
|
|
Risks of COVID-19 Infection and Mortality for Patients on Biologics
 Nikolai Klebanov, MD
Harvard University
 Mentor: Charles Ellis, MD
University of Michigan
|
|
Comparing Compliance Rates of AD Patients on Systemic Meds with those of Psoriasis Patients on Systemic Meds: A National Retrospective Study Using the VA Database
 Reid Waldman, MD
University of Connecticut
 Mentor: Neal Bhatia, MD
UCLA Harbor Medical Center
|
|
|
|
